AGF US Market Neutral Anti-Beta Fund

BTAL

Market cap $303M

BTAL Hedge Fund Activity: Q1 2026 in Review

87 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in AGF US Market Neutral Anti-Beta Fund (BTAL) for Q1 2026, worth a combined $270M — up 55% from $175M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new BTAL positions and 11 closed out — a net gain of 8 holders — while 36 added to existing stakes and 24 trimmed.

The largest buyer was Pasadena Private Wealth, opening a new position worth an estimated $32.1M. The largest seller was Belpointe Asset Management, cutting an estimated $2.5M.

• 87 institutional investors held AGF US Market Neutral Anti-Beta Fund (BTAL) as of Q1 2026, up from 81 in Q4 2025.
• Funds reported $270M of AGF US Market Neutral Anti-Beta Fund stock for Q1 2026, up 55% quarter-over-quarter.
• 19 funds opened new AGF US Market Neutral Anti-Beta Fund positions in Q1 2026 and 11 closed out, a net change of +8 holders.
• The largest AGF US Market Neutral Anti-Beta Fund buyer in Q1 2026 was Pasadena Private Wealth, an estimated $32.1M added.
• The largest AGF US Market Neutral Anti-Beta Fund seller in Q1 2026 was Belpointe Asset Management, an estimated $2.5M sold.

Based on aggregated 13F filings for Q1 2026.